-
DPP9 Mutation Drives HLH-Like Hyperinflammation
2026-08-28
Wolf and colleagues identify a de novo DPP9 mutation that destabilizes the protein and removes restraint from the NLRP1 and CARD8 inflammasomes. The work connects defective intracellular protease regulation with infancy-onset hemophagocytic lymphohistiocytosis-like inflammation and provides a framework for studying inflammasome control in patient-derived models.
-
Spleen-Targeted mRNA Vaccine Rebuilds HCC Immunity
2026-08-28
Lin et al. developed a spleen-targeted neoantigen mRNA vaccine that generated ISG15-positive CD8-positive T cells and promoted tertiary lymphoid structure formation in hepatocellular carcinoma. The study connects organ-selective delivery with a GZMA–F2R interaction between cytotoxic T cells and antigen-presenting cells, offering a mechanistic framework for improving mRNA vaccine design in immune-refractory tumors.
-
5-EdU for S-Phase DNA Synthesis Workflows
2026-08-27
5-Ethynyl-2'-deoxyuridine (5-EdU) enables rapid, antibody-free labeling of newly synthesized DNA for imaging and flow cytometry. This guide translates the method into practical cardiomyocyte, tumor growth research, and tissue regeneration workflows, with controls and troubleshooting for distinguishing proliferation from endoreplication.
-
Bazedoxifene Workflows for ER and IL-6 Research
2026-08-27
Bazedoxifene is a selective estrogen receptor modulator that supports both estrogen receptor signaling studies and emerging IL-6/GP130 pathway research. This practical guide connects dose design, cell-based assays, pathway validation, and troubleshooting for osteoporosis and oncology-focused workflows.
-
Lamotrigine in Neurocardiac Assay Design
2026-08-26
Lamotrigine supports parallel studies of neuronal excitability, serotonin signaling, and cardiac electrophysiology. This workflow combines concentration-response phenotyping with transcriptomics to distinguish sodium-channel activity from cytotoxicity and vehicle artifacts.
-
Silymarin Workflows with Silybin A
2026-08-26
Silybin A provides a defined, QC-supported way to examine Silymarin biology in liver, adipocyte, and immunometabolic assays. This workflow connects adipocyte-targeted Fabp4 CRISPRi with practical small-molecule controls while emphasizing solubility, timing, and assay reproducibility.
-
CFDA-SE Workflows for Proliferation Tracking
2026-08-25
CFDA-SE converts intracellular esterase activity into a division-sensitive fluorescence signal for tracking lymphocytes, fibroblasts, NK cells, bacteria, and migrating populations. This practical workflow also shows how dye-based phenotyping can complement nanobody-TurboID surfaceome studies without confusing behavioral readouts with molecular mechanism.
-
Dextrose (D-Glucose) in Metabolism Research
2026-08-25
Dextrose, or D-glucose, is a soluble monosaccharide used as a defined substrate in glucose metabolism research, cell culture media supplementation, and cellular energy production studies. Its value is experimental control: researchers can vary glucose availability while separately controlling oxygen, pH, nutrients, and cell state.
-
Mouse Neutrophil Cell Isolation Kit Workflow
2026-08-24
Build a rapid, column-free workflow for high-purity mouse neutrophils from bone marrow, blood, or spleen while minimizing target-cell labeling and unwanted activation. The approach is especially useful for functional assays that test neutrophil-targeted mRNA nanovaccines and tumor-immunity mechanisms.
-
LRPPRC–Dasatinib Dual OXPHOS Disruption
2026-08-24
The reference study identifies dasatinib as a synergistic partner for LRPPRC inhibition and explains the effect through complementary suppression of nuclear- and mitochondrial genome-encoded OXPHOS programs. Its findings support a dual-genome strategy for testing OXPHOS-dependent cancers while highlighting the need for in vivo validation and biomarker-guided combination studies.
-
Viral RIPK3 Degradation Controls Necroptosis
2026-08-23
Liu and colleagues identify a viral inducer of RIPK3 degradation (vIRD) that hijacks the host SCF ubiquitin ligase machinery to drive proteasome-dependent loss of RIPK3 and suppress necroptosis. Genetic, virological, and mouse experiments show that this mechanism regulates orthopoxvirus replication, inflammation, and mortality, providing a mechanistic link between pathogen evolution and inflammatory cell death.
-
Annexin V-FITC/7-AAD Apoptosis Kit: Signal to Decision
2026-08-22
The Annexin V-FITC/7-AAD Apoptosis Kit converts phosphatidylserine exposure and membrane permeability into a practical cell death analysis. This article shows how findings on rapid microwave processing can sharpen assay timing, controls, and interpretation without confusing a phenotypic readout with a mechanistic diagnosis.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-22
Saito and colleagues established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be propagated, cryopreserved, and differentiated into epithelial cells with intestinal drug-metabolizing enzyme and transporter activities, providing a more human-relevant platform for oral drug pharmacokinetic studies.
-
SB743921: From Mitotic Arrest to Translational Insight
2026-08-21
SB743921 is a highly selective kinesin spindle protein inhibitor that offers more than a potent antiproliferative phenotype. By pairing its mitotic mechanism with disciplined viability and cell-death measurements, translational researchers can improve assay interpretation, model selection, and the path from cancer research to preclinical decision-making.
-
Rotigotine Workflows for Parkinson’s Disease Research
2026-08-20
Build reproducible Rotigotine experiments around receptor pharmacology, solvent control, and exposure pattern rather than dose alone. This guide connects cell-based assays, PD animal models, bladder-function studies, and continuous-delivery concepts to practical troubleshooting decisions.